Serum Ferritin Levels in Pregnancy and Their Association with Gestational Diabetes Mellitus: A Prospective Longitudinal Study.

OBJECTIVE

Elevated serum ferritin (SF) levels are associated with oxidative stress (OS) and systemic inflammation in various disorders. However, the changes in SF levels during pregnancy and their relationship with gestational diabetes mellitus (GDM) and blood glucose levels are not well understood.

METHODS

This prospective longitudinal study included 390 participants (130 GDM cases and 260 controls) during early pregnancy. We measured SF levels in the1, 2, and 3 trimesters, as well as plasma malondialdehyde (MDA) and C-reactive protein (CRP) in the 1 trimester, blood glucose levels in the oral glucose tolerance test (OGTT), and glycosylated hemoglobin (HbA1c) in the 2 trimester. We used Spearman's rank correlation to estimate the association between SF, OS, inflammation and glucose levels. Logistic regression analysis was performed to estimate the OR of GDM associated with SF. Multiple stepwise regression models were used to assess the relationship between glucose levels and the risk factors.

RESULTS

SF levels decreased with increasing gestation in the study population. Compared to controls, GDM patients had significantly higher levels of SF (1 and 2 trimesters), MDA, CRP, and HbA1c. SF was positively correlated with MDA and fasting plasma glucose (FPG). Elevated SF levels during early pregnancy were significantly associated with increased GDM risks (OR = 2.024, 95% CI: 1.076 - 3.807). The explanatory variables that contributed to increased glucose levels were SF, MDA, body mass index (BMI), maternal age, and family history of diabetes.

CONCLUSION

SF is significantly associated with GDM and may be a potential biomarker for GDM in early pregnancy.